Dual Balloon Angioplasty Catheter Market Snapshot (2023 to 2033)

The global dual balloon angioplasty catheter market was valued at US$ 199.8 million in 2022. In 2023, this overall market value is projected to reach US$ 204.9 million. During the forecast year from 2023 to 2033, the global adoption of dual balloon angioplasty catheters could witness a CAGR of 3.2%. Furthermore, FMI predicts the global market to be valued at nearly US$ 281.3 million by the end of this forecast period. Growth is attributed to the increasing prevalence of cardiovascular disorders. Between 2018 and 2022, a CAGR of 2% was registered for the overall market.

Dual balloon angioplasty catheter is a medical device inserted into the artery to clear the blockage and allow the clogged blood to flow. Dual balloon angioplasty is done to prevent heart attack and angina in patients who have coronary artery disease.

Dual balloon angioplasty catheter is less invasive as compared to bypass surgery, which was the only option before. Balloon angioplasty widens the narrowed blood vessel by inflating the balloon, which expands the area in the artery. Dual balloon angioplasty catheter is a thin plastic and flexible tube with a tiny balloon, and its tip is used to inject fluids and measure blood pressure.

Sometimes, stents are inserted by placing them on the tip of the balloon in the dual balloon angioplasty to keep the artery wall expanded. X-ray is used in dual balloon angioplasty to guide the catheter into the heart and arteries. Dye is injected into the body to highlight the blood arteries. Dual balloon angioplasty catheter resolves the difficulties, such as insertion and removal of the large catheter.

Firm pressure is applied to the site of the catheter to stop the bleeding. Dual balloon angioplasty is usually done when the cholesterol plaque builds up in the wall of the artery of the heart, thus allowing more blood and oxygen to flow into the muscles of the heart.

Attributes Details
Global Dual Balloon Angioplasty Catheter Market Valuation in 2022 US$ 199.8 million
Estimated Global Market Share in 2023 US$ 204.9 million
Forecasted Global Market Size by 2033 US$ 281.3 million
Projected Global Market Growth Rate from 2023 to 2033 3.2% CAGR
Historical Market Growth Rate from 2018 to 2022 2% CAGR

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Some Prominent Drivers Spearheading Dual Balloon Angioplasty Catheter Market Growth

A dual balloon angioplasty catheter is simple and easy. An increase in the prevalence of cardiac disorders and drugs can be delivered directly to the affected area by the soft and flexible catheter, which drives the market's growth.

The peripheral and coronary angioplasty market continues to grow in the coming years due to an increase in cardiovascular disease, obesity, and diabetes, boosting the growth of the overall market.

Challenges Faced by the Dual Balloon Angioplasty Catheter Industry

Due to some drawbacks of the procedure, less preference for dual balloon angioplasty by patients presents a considerable limitation to the growth of the dual-balloon angioplasty catheters market. Patients may need to perform a repeat procedure as the arteries eventually may get blocked several years after angioplasty.

Category By Indication
Top Segment Coronary
Market Share in Percentage 71.2%
Category By End User
Top Segment Hospital
Market Share in Percentage 66.2%
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

North America is Emerging as an Opportunistic Dual Balloon Angioplasty Catheter Market

North America accounted for nearly 33.7% of the global market in 2022. Demand for balloon catheters may rise due to the presence of leading manufacturers, increased patient awareness, advanced healthcare facilities and infrastructure availability, and technological advancements.

The growth of the market in the region is attributed to the increasing awareness of treatment options and general health awareness in these regions, along with the impact of the rising prevalence of related illnesses.

To improve the existing products to get better results, some leading players in the region are focusing on novel product launches. They also invest extensively in research and development activities to develop advanced dual balloon angioplasty catheters.

Regional Market Comparison Global Market Share in Percentage
North America 33.7%
Europe 28.2%

Europe is Contributing Significantly to the Dual Balloon Angioplasty Catheter Market Growth

Europe accounted for almost 28.2% of the global market share in 2022. Growth in the region is underpinned by a growing aging population, efficient healthcare infrastructure, and an emphasis on the development of innovative technology and enhanced patient diagnosis.

Increasing minimally invasive surgical interventions, increased emphasis on research and development capabilities in medical devices and on the adoption of advanced healthcare technologies, an increase in robotic-assisted surgical procedures, and rising expenditure on healthcare infrastructure development are the key factors driving the growth of the market in this region.

Regional Market Comparison Global Market Share in Percentage
United States 31%
Germany 8.2%
Japan 7.1%

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Asia Pacific May Emerge as an Attractive Dual Balloon Angioplasty Catheter Market

The Asia Pacific is anticipated to gain market share during the forecast period. Product launches, acquisitions, distribution agreements, alliances, and geographical expansion by local players, especially in China and India, are expected to propel the region's dual balloon angioplasty catheter market.

The fast pace of growth of this regional market can also be attributed to growing consciousness regarding Percutaneous Coronary Intervention (PCI) procedures, coupled with the increasing adoption of cost-effective and minimally-invasive methods.

Manufacturers in the dual balloons angioplasty catheter market are looking to cash in on this trend and establish themselves in APAC to gain a stronger foothold in the global angioplasty balloons market.

Regional Markets CAGR (2023 to 2033)
United Kingdom 2.2%
China 3.9%
India 3.2%
Australia 2.8%

Start-up Scenario

The new entrants in the dual balloon angioplasty catheter market continually indulge in collaborations and highly invest in research and development activities to provide more convenient solutions to industry verticals. Some leading start-ups that are leading the development of the market are – Manishmedi Innovation, Advin Health Care, and Ridgeback Technologies Private Limited

Ridgeback Technology Private Ltd. specializes in designing, developing, and manufacturing leading-edge catheter balloons.

Market Competition

Key participants in the global dual balloon angioplasty catheter market include Spectranetics, InSitu Technologies Inc, eucatech AG, Balton Sp. z o.o., PanMed Us, Degania Silicone Ltd, Van Oostveen Medical B.V., IMeSI, phenox GmbH, Natec Medical, Acrostak Int., and SCITECH, Medinol Ltd. among others.

The market is highly competitive due to the presence of such leading participants. While global players such as Spectranetics, InSitu Technologies Inc, eucatech AG, Balton Sp. z o.o., PanMed Us, and Degania Silicone Ltd account for a considerable market size, and several regional-level players are also operating across key growth regions, particularly in the Asia Pacific.

In May 2020 - Zavation Medical Products, an innovative designer and manufacturer of high-quality spinal implants, instruments, MIS procedural kits, and biologics headquartered in Flowood, MS, announced the launch of eZspand, an expandable lumbar interbody fusion device.

Scope of the Market Report

Attributes Details
Growth Rate CAGR of 3.2% from 2023 to 2033
Expected Market Value (2023) US$ 204.9 million
Anticipated Forecast Value (2033) US$ 281.3 million
Base Year for Estimation 2022
Historical Data 2018 to 2022
Forecast Period 2023 to 2033
Quantitative Units Revenue in US$ million and CAGR from 2023 to 2033
Report Coverage Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis
Segments Covered Indication, End User, Region
Regions Covered North America; Latin America; Europe; Asia Pacific; The Middle East and Africa
Key Countries Profiled United States, Canada, Mexico, Brazil, Germany, France, United Kingdom, Spain, China, Japan, South Korea, GCC, South Africa, Israel
Key Companies Profiled Spectranetics; InSitu Technologies Inc.; Eucatech AG; Balton Sp. z o.o.; PanMed; Degania Silicone Ltd; Romed Holland; IMeSI; phenox GmbH; Natec Medical; Acrostak; SCITECH; Medinol Ltd.
Customization & Pricing Available Upon Request

Key Segments Profiled in the Dual Balloon Angioplasty Catheter Industry Survey

By Indication:

  • Peripheral
  • Coronal

By End User:

  • Hospitals
  • Catheterization Labs

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • The Middle East and Africa

Frequently Asked Questions

Which Countries Dominate the Global Market?

The United States, India, and Germany dominate the global market.

What is the Growth Forecast for the Dual Balloon Angioplasty Catheter Market?

The market is forecast to register a CAGR of 3.2% through 2033.

How is the Historical Performance of the Market?

From 2018 to 2022, the market registered a CAGR of 2%.

Which is the Top Trend in the Dual Balloon Angioplasty Catheter Market?

Technological advancement disrupts the current market trends.

What is the Projected Size of the Market by 2033?

The global market size is to reach US$ 281.3 million by 2033.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Product Life Cycle Analysis

    3.5. Supply Chain Analysis

        3.5.1. Supply Side Participants and their Roles

            3.5.1.1. Producers

            3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)

            3.5.1.3. Wholesalers and Distributors

        3.5.2. Value Added and Value Created at Node in the Supply Chain

        3.5.3. List of Raw Material Suppliers

        3.5.4. List of Existing and Potential Buyer’s

    3.6. Investment Feasibility Matrix

    3.7. Value Chain Analysis

        3.7.1. Profit Margin Analysis

        3.7.2. Wholesalers and Distributors

        3.7.3. Retailers

    3.8. PESTLE and Porter’s Analysis

    3.9. Regulatory Landscape

        3.9.1. By Key Regions

        3.9.2. By Key Countries

    3.10. Regional Parent Market Outlook

    3.11. Production and Consumption Statistics

    3.12. Import and Export Statistics

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Indication, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Indication, 2023 to 2033

        5.3.1. Peripheral

        5.3.2. Coronal

    5.4. Y-o-Y Growth Trend Analysis By Indication, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Indication, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End–User

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End–User, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End–User, 2023 to 2033

        6.3.1. Hospitals

        6.3.2. Catheterization Labs

    6.4. Y-o-Y Growth Trend Analysis By End–User, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By End–User, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    7.1. Introduction

    7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022

    7.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033

        7.3.1. North America

        7.3.2. Latin America

        7.3.3. Western Europe

        7.3.4. Eastern Europe

        7.3.5. South Asia and Pacific

        7.3.6. East Asia

        7.3.7. Middle East and Africa

    7.4. Market Attractiveness Analysis By Region

8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    8.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    8.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        8.2.1. By Country

            8.2.1.1. The USA

            8.2.1.2. Canada

        8.2.2. By Indication

        8.2.3. By End–User

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Indication

        8.3.3. By End–User

    8.4. Key Takeaways

9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. Brazil

            9.2.1.2. Mexico

            9.2.1.3. Rest of Latin America

        9.2.2. By Indication

        9.2.3. By End–User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Indication

        9.3.3. By End–User

    9.4. Key Takeaways

10. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. Germany

            10.2.1.2. United Kingdom

            10.2.1.3. France

            10.2.1.4. Spain

            10.2.1.5. Italy

            10.2.1.6. Rest of Western Europe

        10.2.2. By Indication

        10.2.3. By End–User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Indication

        10.3.3. By End–User

    10.4. Key Takeaways

11. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Poland

            11.2.1.2. Russia

            11.2.1.3. Czech Republic

            11.2.1.4. Romania

            11.2.1.5. Rest of Eastern Europe

        11.2.2. By Indication

        11.2.3. By End–User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Indication

        11.3.3. By End–User

    11.4. Key Takeaways

12. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. India

            12.2.1.2. Bangladesh

            12.2.1.3. Australia

            12.2.1.4. New Zealand

            12.2.1.5. Rest of South Asia and Pacific

        12.2.2. By Indication

        12.2.3. By End–User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Indication

        12.3.3. By End–User

    12.4. Key Takeaways

13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. China

            13.2.1.2. Japan

            13.2.1.3. South Korea

        13.2.2. By Indication

        13.2.3. By End–User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Indication

        13.3.3. By End–User

    13.4. Key Takeaways

14. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. GCC Countries

            14.2.1.2. South Africa

            14.2.1.3. Israel

            14.2.1.4. Rest of MEA

        14.2.2. By Indication

        14.2.3. By End–User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Indication

        14.3.3. By End–User

    14.4. Key Takeaways

15. Key Countries Market Analysis

    15.1. USA

        15.1.1. Pricing Analysis

        15.1.2. Market Share Analysis, 2022

            15.1.2.1. By Indication

            15.1.2.2. By End–User

    15.2. Canada

        15.2.1. Pricing Analysis

        15.2.2. Market Share Analysis, 2022

            15.2.2.1. By Indication

            15.2.2.2. By End–User

    15.3. Brazil

        15.3.1. Pricing Analysis

        15.3.2. Market Share Analysis, 2022

            15.3.2.1. By Indication

            15.3.2.2. By End–User

    15.4. Mexico

        15.4.1. Pricing Analysis

        15.4.2. Market Share Analysis, 2022

            15.4.2.1. By Indication

            15.4.2.2. By End–User

    15.5. Germany

        15.5.1. Pricing Analysis

        15.5.2. Market Share Analysis, 2022

            15.5.2.1. By Indication

            15.5.2.2. By End–User

    15.6. United Kingdom

        15.6.1. Pricing Analysis

        15.6.2. Market Share Analysis, 2022

            15.6.2.1. By Indication

            15.6.2.2. By End–User

    15.7. France

        15.7.1. Pricing Analysis

        15.7.2. Market Share Analysis, 2022

            15.7.2.1. By Indication

            15.7.2.2. By End–User

    15.8. Spain

        15.8.1. Pricing Analysis

        15.8.2. Market Share Analysis, 2022

            15.8.2.1. By Indication

            15.8.2.2. By End–User

    15.9. Italy

        15.9.1. Pricing Analysis

        15.9.2. Market Share Analysis, 2022

            15.9.2.1. By Indication

            15.9.2.2. By End–User

    15.10. Poland

        15.10.1. Pricing Analysis

        15.10.2. Market Share Analysis, 2022

            15.10.2.1. By Indication

            15.10.2.2. By End–User

    15.11. Russia

        15.11.1. Pricing Analysis

        15.11.2. Market Share Analysis, 2022

            15.11.2.1. By Indication

            15.11.2.2. By End–User

    15.12. Czech Republic

        15.12.1. Pricing Analysis

        15.12.2. Market Share Analysis, 2022

            15.12.2.1. By Indication

            15.12.2.2. By End–User

    15.13. Romania

        15.13.1. Pricing Analysis

        15.13.2. Market Share Analysis, 2022

            15.13.2.1. By Indication

            15.13.2.2. By End–User

    15.14. India

        15.14.1. Pricing Analysis

        15.14.2. Market Share Analysis, 2022

            15.14.2.1. By Indication

            15.14.2.2. By End–User

    15.15. Bangladesh

        15.15.1. Pricing Analysis

        15.15.2. Market Share Analysis, 2022

            15.15.2.1. By Indication

            15.15.2.2. By End–User

    15.16. Australia

        15.16.1. Pricing Analysis

        15.16.2. Market Share Analysis, 2022

            15.16.2.1. By Indication

            15.16.2.2. By End–User

    15.17. New Zealand

        15.17.1. Pricing Analysis

        15.17.2. Market Share Analysis, 2022

            15.17.2.1. By Indication

            15.17.2.2. By End–User

    15.18. China

        15.18.1. Pricing Analysis

        15.18.2. Market Share Analysis, 2022

            15.18.2.1. By Indication

            15.18.2.2. By End–User

    15.19. Japan

        15.19.1. Pricing Analysis

        15.19.2. Market Share Analysis, 2022

            15.19.2.1. By Indication

            15.19.2.2. By End–User

    15.20. South Korea

        15.20.1. Pricing Analysis

        15.20.2. Market Share Analysis, 2022

            15.20.2.1. By Indication

            15.20.2.2. By End–User

    15.21. GCC Countries

        15.21.1. Pricing Analysis

        15.21.2. Market Share Analysis, 2022

            15.21.2.1. By Indication

            15.21.2.2. By End–User

    15.22. South Africa

        15.22.1. Pricing Analysis

        15.22.2. Market Share Analysis, 2022

            15.22.2.1. By Indication

            15.22.2.2. By End–User

    15.23. Israel

        15.23.1. Pricing Analysis

        15.23.2. Market Share Analysis, 2022

            15.23.2.1. By Indication

            15.23.2.2. By End–User

16. Market Structure Analysis

    16.1. Competition Dashboard

    16.2. Competition Benchmarking

    16.3. Market Share Analysis of Top Players

        16.3.1. By Regional

        16.3.2. By Indication

        16.3.3. By End–User

17. Competition Analysis

    17.1. Competition Deep Dive

        17.1.1. Spectranetics

            17.1.1.1. Overview

            17.1.1.2. Product Portfolio

            17.1.1.3. Profitability by Market Segments

            17.1.1.4. Sales Footprint

            17.1.1.5. Strategy Overview

                17.1.1.5.1. Marketing Strategy

                17.1.1.5.2. Product Strategy

                17.1.1.5.3. Channel Strategy

        17.1.2. InSitu Technologies® Inc.

            17.1.2.1. Overview

            17.1.2.2. Product Portfolio

            17.1.2.3. Profitability by Market Segments

            17.1.2.4. Sales Footprint

            17.1.2.5. Strategy Overview

                17.1.2.5.1. Marketing Strategy

                17.1.2.5.2. Product Strategy

                17.1.2.5.3. Channel Strategy

        17.1.3. Eucatech AG

            17.1.3.1. Overview

            17.1.3.2. Product Portfolio

            17.1.3.3. Profitability by Market Segments

            17.1.3.4. Sales Footprint

            17.1.3.5. Strategy Overview

                17.1.3.5.1. Marketing Strategy

                17.1.3.5.2. Product Strategy

                17.1.3.5.3. Channel Strategy

        17.1.4. Balton Sp. z o.o.

            17.1.4.1. Overview

            17.1.4.2. Product Portfolio

            17.1.4.3. Profitability by Market Segments

            17.1.4.4. Sales Footprint

            17.1.4.5. Strategy Overview

                17.1.4.5.1. Marketing Strategy

                17.1.4.5.2. Product Strategy

                17.1.4.5.3. Channel Strategy

        17.1.5. PanMed

            17.1.5.1. Overview

            17.1.5.2. Product Portfolio

            17.1.5.3. Profitability by Market Segments

            17.1.5.4. Sales Footprint

            17.1.5.5. Strategy Overview

                17.1.5.5.1. Marketing Strategy

                17.1.5.5.2. Product Strategy

                17.1.5.5.3. Channel Strategy

        17.1.6. Degania Silicone Ltd

            17.1.6.1. Overview

            17.1.6.2. Product Portfolio

            17.1.6.3. Profitability by Market Segments

            17.1.6.4. Sales Footprint

            17.1.6.5. Strategy Overview

                17.1.6.5.1. Marketing Strategy

                17.1.6.5.2. Product Strategy

                17.1.6.5.3. Channel Strategy

        17.1.7. Romed Holland

            17.1.7.1. Overview

            17.1.7.2. Product Portfolio

            17.1.7.3. Profitability by Market Segments

            17.1.7.4. Sales Footprint

            17.1.7.5. Strategy Overview

                17.1.7.5.1. Marketing Strategy

                17.1.7.5.2. Product Strategy

                17.1.7.5.3. Channel Strategy

        17.1.8. IMeSI

            17.1.8.1. Overview

            17.1.8.2. Product Portfolio

            17.1.8.3. Profitability by Market Segments

            17.1.8.4. Sales Footprint

            17.1.8.5. Strategy Overview

                17.1.8.5.1. Marketing Strategy

                17.1.8.5.2. Product Strategy

                17.1.8.5.3. Channel Strategy

        17.1.9. phenox GmbH

            17.1.9.1. Overview

            17.1.9.2. Product Portfolio

            17.1.9.3. Profitability by Market Segments

            17.1.9.4. Sales Footprint

            17.1.9.5. Strategy Overview

                17.1.9.5.1. Marketing Strategy

                17.1.9.5.2. Product Strategy

                17.1.9.5.3. Channel Strategy

        17.1.10. Natec Medical

            17.1.10.1. Overview

            17.1.10.2. Product Portfolio

            17.1.10.3. Profitability by Market Segments

            17.1.10.4. Sales Footprint

            17.1.10.5. Strategy Overview

                17.1.10.5.1. Marketing Strategy

                17.1.10.5.2. Product Strategy

                17.1.10.5.3. Channel Strategy

        17.1.11. Acrostak

            17.1.11.1. Overview

            17.1.11.2. Product Portfolio

            17.1.11.3. Profitability by Market Segments

            17.1.11.4. Sales Footprint

            17.1.11.5. Strategy Overview

                17.1.11.5.1. Marketing Strategy

                17.1.11.5.2. Product Strategy

                17.1.11.5.3. Channel Strategy

        17.1.12. SCITECH

            17.1.12.1. Overview

            17.1.12.2. Product Portfolio

            17.1.12.3. Profitability by Market Segments

            17.1.12.4. Sales Footprint

            17.1.12.5. Strategy Overview

                17.1.12.5.1. Marketing Strategy

                17.1.12.5.2. Product Strategy

                17.1.12.5.3. Channel Strategy

        17.1.13. Medinol Ltd.

            17.1.13.1. Overview

            17.1.13.2. Product Portfolio

            17.1.13.3. Profitability by Market Segments

            17.1.13.4. Sales Footprint

            17.1.13.5. Strategy Overview

                17.1.13.5.1. Marketing Strategy

                17.1.13.5.2. Product Strategy

                17.1.13.5.3. Channel Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

Recommendations

Healthcare

Catheter Associated Urinary Tract Infections (UTI) Treatment Market

October 2020

REP-GB-12575

June 2023

220 pages

Healthcare

Stent Graft Balloon Catheter Market

September 2024

REP-GB-1628

Upcoming

Explore Healthcare Insights

View Reports
Future Market Insights

Dual Balloon Angioplasty Catheter Market